SYNLAB AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.28 EUR | -2.47% |
|
-5.86% | -9.90% |
| Apr. 15 | SYNLAB AG(XTRA:SYAB) dropped from S&P Global BMI Index | CI |
| Apr. 05 | Tranche Update on SYNLAB AG's Equity Buyback Plan announced on September 22, 2022. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Synlab AG is a Germany based clinical laboratory and medical diagnostic services provider. The Company is engaged in laboratory services for human and veterinary medicine, as well as environmental analysis.
Calendar
2024-05-07
- Q1 2024 Earnings Call
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
10.54
EUR
Average target price
14.5
EUR
Spread / Average Target
+37.57%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -18.11% | 8.02B | |
| +33.79% | 3.51B | |
| -29.02% | 2.97B | |
| -14.30% | 2.23B | |
| -16.38% | 1.76B | |
| -22.17% | 1.44B | |
| -39.69% | 1.25B | |
| -11.20% | 1.11B | |
| +3.66% | 1.07B |
- Stock Market
- Equities
- SYAB Stock
- SYAB Stock
- News SYNLAB AG
- SYNLAB Completes Purchase of Mexican Diagnostics Services Providers
